BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26318820)

  • 21. Angiomyolipoma with minimal fat: differentiation from papillary renal cell carcinoma by helical CT.
    Zhang YY; Luo S; Liu Y; Xu RT
    Clin Radiol; 2013 Apr; 68(4):365-70. PubMed ID: 23321146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
    Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
    AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging.
    Lyu HL; Cao JX; Wang HY; Wang ZB; Hu MG; Ma L; Wang YW; Ye HY
    Abdom Radiol (NY); 2018 Oct; 43(10):2712-2720. PubMed ID: 29500651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.
    Jilesen AP; Hoefnagel SJ; Busch OR; Bennink RJ; Gouma DJ; Nieveen van Dijkum EJ
    Clin Radiol; 2016 Jun; 71(6):537-42. PubMed ID: 27016111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
    Brook OR; Gourtsoyianni S; Brook A; Siewert B; Kent T; Raptopoulos V
    Radiology; 2013 Oct; 269(1):139-48. PubMed ID: 23674791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.
    Kim C; Byun JH; Hong SM; An S; Kim JH; Lee SS; Kim HJ
    Abdom Radiol (NY); 2017 Dec; 42(12):2835-2842. PubMed ID: 28624923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.
    Choi TW; Kim JH; Yu MH; Park SJ; Han JK
    Acta Radiol; 2018 Apr; 59(4):383-392. PubMed ID: 28766979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Hatemura M; Yamashita Y
    Radiology; 2007 Nov; 245(2):475-82. PubMed ID: 17890356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
    Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
    HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.
    Kim JK; Park SY; Shon JH; Cho KS
    Radiology; 2004 Mar; 230(3):677-84. PubMed ID: 14990834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between solid pseudopapillary neoplasm of the pancreas and hypovascular pancreatic neuroendocrine tumors by using computed tomography.
    Wang C; Cui W; Wang J; Chen X; Tong H; Wang Z
    Acta Radiol; 2019 Oct; 60(10):1216-1223. PubMed ID: 30678482
    [No Abstract]   [Full Text] [Related]  

  • 36. Is hypervascular papillary renal cell carcinoma present?
    Yamamoto T; Gulanbar A; Hayashi K; Kohno A; Komai Y; Yonese J; Matsueda K; Inamura K
    Abdom Radiol (NY); 2021 Apr; 46(4):1687-1693. PubMed ID: 33047228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT.
    Bata P; Gyebnar J; Tarnoki DL; Tarnoki AD; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
    Diagn Interv Radiol; 2013; 19(5):387-92. PubMed ID: 23864331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted MRI: usefulness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas.
    Kang BK; Kim JH; Byun JH; Lee SS; Kim HJ; Kim SY; Lee MG
    Acta Radiol; 2014 Dec; 55(10):1157-65. PubMed ID: 24259300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT.
    Jang KM; Kim SH; Song KD; Kim YK; Lee SJ; Choi D
    Clin Radiol; 2015 Feb; 70(2):153-60. PubMed ID: 25465293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.